ストックスクリーナーアプリを入手
1.35
1.50%
0.02
アフターアワーズ：
1.37
0.02
+1.48%
Cardiff Oncology Inc (CRDF) 最新ニュース
Enterprise value to EBIT forward of Cardiff Oncology, Inc. – FWB:XE7C - TradingView
CRDF Q1 2026 Earnings: EPS Miss Sends Mixed Signals Despite Modest Stock GainPerformance Review - dars.gov.et
Cardiff Oncology (CRDF) Noble Capital Markets Emerging Growth Virtual Investor Conference summary - Quartr
Price to earnings forward of Cardiff Oncology, Inc. – NASDAQ:CRDF - TradingView
Price to earnings forward of Cardiff Oncology, Inc. – TRADEGATE:XE7C - TradingView
Enterprise value to EBIT forward of Cardiff Oncology, Inc. – TRADEGATE:XE7C - TradingView
Price to book forward of Cardiff Oncology, Inc. – NASDAQ:CRDF - TradingView
CRDFCardiff Oncology Inc Dividends - Finviz
Is Cardiff Oncology, Inc. (CRDF) Stock Undervalued Amid Legal Uncertainty and Future Cancer Drug Potential? - Yahoo Finance
Cardiff Oncology, Inc.(NasdaqCM:CRDF) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 2000 Value Benchmark - marketscreener.com
Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 2000 Dynamic Index - marketscreener.com
Cardiff Oncology, Inc.(NasdaqCM:CRDF) dropped from Russell Small Cap Completeness Index - marketscreener.com
Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 2500 Index - marketscreener.com
Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 3000 Index - marketscreener.com
Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 2000 Index - marketscreener.com
Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 3000E Value Benchmark - marketscreener.com
Cardiff Oncology, Inc.(NasdaqCM: CRDF) dropped from Russell 3000 Growth Benchmark - marketscreener.com
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director TANNENBAUM RENEE P - Moomoo
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director PACE GARY W - Moomoo
Cardiff Oncology, Inc. Actuals & Estimates (NASDAQ:CRDF) - TradingView
Cardiff Oncology, Inc. Actuals & Estimates (FWB:XE7C) - TradingView
Cardiff Oncology Inc (CRDF) Institutional Confidence - TradingKey
Cardiff Oncology, Inc. Actuals & Estimates (LS:A2P4GU) - TradingView
CRDF Forecast — Price Target — Prediction for 2027 - TradingView
CRDF Q1 2026 Earnings: EPS Misses Estimates as Clinical Progress Remains FocusLong-Term Guidance - dars.gov.et
CRDF News | CARDIFF ONCOLOGY INC (NASDAQ:CRDF) - ChartMill
Cardiff Oncology Inc (CRDF) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Daily Brief Health Care: Abbvie Inc, Blueprint Medicines, Cardiff Oncology, Fusion Antibodies , Guangdong True Health Medical Technology Development, High Tide , Nasos Pharma, Teladoc Health, Inc. and more - Smartkarma
Cardiff Oncology director Gary Pace buys $36,600 in stock By Investing.com - Investing.com Australia
CRDF: Phase II Update; Survival Advantage Extended - scr.zacks.com
Cardiff Oncology director Gary Pace buys $36,600 in stock - Investing.com UK
Insider Buying: Mani Mohindru Acquires Shares of Cardiff Oncology Inc (CRDF) - GuruFocus
Cardiff Oncology CEO Mani Mohindru buys $29,890 in company stock By Investing.com - Investing.com Nigeria
Cardiff Oncology CEO Mani Mohindru buys $29,890 in company stock - Investing.com
Form 4 Cardiff Oncology Inc For: 22 June By Investing.com - Investing.com Nigeria
Cardiff Oncology (CRDF) director Gary W. Pace buys 30,000 shares in open market - Stock Titan
Cardiff Oncology (CRDF) CEO makes open-market buy of 24,703 shares - Stock Titan
Cardiff Oncology (CRDF) Stifel 2025 Healthcare Conference Summary - Quartr
Cardiff Oncology (CRDF) Proxy filing Summary - Quartr
Cardiff Oncology Inc (CRDF) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cardiff Oncology Inc (CRDF) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cardiff Oncology Inc (CRDF) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cardiff Oncology Inc (CRDF) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cardiff Oncology Inc (CRDF) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cardiff Oncology Inc (CRDF) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cardiff Oncology Inc (CRDF) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cardiff Oncology (CRDF) director receives 40,565 stock options at $1.59 strike - Stock Titan
Cardiff Oncology (CRDF) director receives grant of 40,565 stock options at $1.59 - Stock Titan
Cardiff Oncology Shareholders Approve Directors and Equity Plan - TipRanks
Cardiff Oncology (CRDF) shareholders back board, auditor and equity plan - Stock Titan
5.60%
0.04%
大文字化:
|
ボリューム (24 時間):